top of page
About the Trial
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study: Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably. The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of the lungs in asthmatic participants with type 2 inflammation, characterized by an eosinophilic phenotype.
Mechanism of Action:
Long anti IL-5
Duration of Study
~64 weeks
Phase
III
Principal Investigator
Dr. George Philteos
Sub-Investigator
Dr. Anushya Chelvanathan
Study Coordinator
Kesana Vijeyaratnam
bottom of page

